跳轉至內容
Merck

1.00490

SAFC

Parteck®口腔崩解片

EMPROVE® ESSENTIAL

製藥生產

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352107

一般說明

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Parteck® ODT excipient provides rapid disintegration and exceptional strength for orally disintegrating tablets. It is well suited for direct compression processes and provides a pleasant taste and mouthfeel.

特點和優勢

  • Robust tablets at low compression forces
  • Rapid disintegration and dissolution
  • No license payments
  • High dilution potential – up to 50% load of your API
  • Tablets with PARTECK® ODT excipient system are suitable for conventional coating

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

客戶也查看了

文章

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

我們對 API 溶解度與溶解度增強方法的概述,可協助您在製劑過程中的許多選擇中作出決定。

This article describes the use of excipients to help address API stability issues.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

查看全部

相關內容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務